Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

ERS statement on chronic thromboembolic pulmonary hypertension

M. Delcroix, A. Torbicki, D. Gopalan, O. Sitbon, FA. Klok, I. Lang, D. Jenkins, NH. Kim, M. Humbert, X. Jais, A. Vonk Noordegraaf, J. Pepke-Zaba, P. Brénot, P. Dorfmuller, E. Fadel, HA. Ghofrani, MM. Hoeper, P. Jansa, M. Madani, H. Matsubara, T....

. 2021 ; 57 (6) : . [pub] 20210617

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc21025560

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries by fibrotic intravascular material, in combination with a secondary microvasculopathy of vessels <500 µm, leads to increased pulmonary vascular resistance and progressive right heart failure. The mechanism responsible for the transformation of red clots into fibrotic material remnants has not yet been elucidated. In patients with pulmonary hypertension, the diagnosis is suspected when a ventilation/perfusion lung scan shows mismatched perfusion defects, and confirmed by right heart catheterisation and vascular imaging. Today, in addition to lifelong anticoagulation, treatment modalities include surgery, angioplasty and medical treatment according to the localisation and characteristics of the lesions.This statement outlines a review of the literature and current practice concerning diagnosis and management of CTEPH. It covers the definitions, diagnosis, epidemiology, follow-up after acute pulmonary embolism, pathophysiology, treatment by pulmonary endarterectomy, balloon pulmonary angioplasty, drugs and their combination, rehabilitation and new lines of research in CTEPH.It represents the first collaboration of the European Respiratory Society, the International CTEPH Association and the European Reference Network-Lung in the pulmonary hypertension domain. The statement summarises current knowledge, but does not make formal recommendations for clinical practice.

2nd Department of Medicine Dept of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

BREATHE Dept CHROMETA KU Leuven Leuven Belgium

Clinical Dept of Respiratory Diseases Pulmonary Hypertension Center UZ Leuven Leuven Belgium

Co chair

Dept of Medicine Imperial College London London UK

Dept of Medicine Thrombosis and Hemostasis Leiden University Medical Center Leiden The Netherlands

Dept of Pneumology Kerckhoff Clinic Bad Nauheim Bad Nauheim Germany

Dept of Pulmonary Circulation Thrombo embolic Diseases and Cardiology Center of Postgraduate Medical Education ECZ Otwock Otwock Poland

Dept of Pulmonary Medicine Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam Cardiovascular Sciences Amsterdam The Netherlands

Dept of Radiology Imperial College Hospitals NHS Trusts London UK

Dept of Thoracic Surgery Kerckhoff Clinic Bad Nauheim Bad Nauheim Germany

Division of Pulmonary Critical Care and Sleep Medicine University of California San Diego La Jolla CA USA

Equal contribution

Hannover Medical School Hannover Germany

Inserm UMR_S 999 Service de Pneumologie Hôpital Bicêtre Le Kremlin Bicêtre France

Institute for Diagnostic and Interventional Radiology Hannover Medical School Hannover Germany

Marie Lannelongue Hospital Paris South University Le Plessis Robinson France

Medical University of Vienna Vienna Austria

National Cerebral and Cardiovascular Centre Osaka Japan

National Hospital Organization Okayama Medical Center Okayama Japan

Patient representative

PHA Europe Hungary

PHA Ireland Dublin Ireland

Royal Papworth Hospital Cambridge University Hospital Cambridge UK

Section editors

Sulpizio Cardiovascular Centre University of California San Diego CA USA

Thoraxklinik Heidelberg at Heidelberg University Hospital Heidelberg Germany

Unit of Cardiac Surgery Intrathoracic Transplantation and Pulmonary Hypertension University of Pavia School of Medicine Foundation 1 R C C S Policlinico San Matteo Pavia Italy

Université Paris Saclay

University of Bologna Bologna Italy

University of Giessen and Marburg Lung Center German Center of Lung Research Giessen Germany

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025560
003      
CZ-PrNML
005      
20211026133714.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1183/13993003.02828-2020 $2 doi
035    __
$a (PubMed)33334946
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Delcroix, Marion $u Clinical Dept of Respiratory Diseases, Pulmonary Hypertension Center, UZ Leuven, Leuven, Belgium marion.delcroix@uzleuven.be $u BREATHE, Dept CHROMETA, KU Leuven, Leuven, Belgium $u Co-chair
245    10
$a ERS statement on chronic thromboembolic pulmonary hypertension / $c M. Delcroix, A. Torbicki, D. Gopalan, O. Sitbon, FA. Klok, I. Lang, D. Jenkins, NH. Kim, M. Humbert, X. Jais, A. Vonk Noordegraaf, J. Pepke-Zaba, P. Brénot, P. Dorfmuller, E. Fadel, HA. Ghofrani, MM. Hoeper, P. Jansa, M. Madani, H. Matsubara, T. Ogo, E. Grünig, A. D'Armini, N. Galie, B. Meyer, P. Corkery, G. Meszaros, E. Mayer, G. Simonneau
520    9_
$a Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries by fibrotic intravascular material, in combination with a secondary microvasculopathy of vessels <500 µm, leads to increased pulmonary vascular resistance and progressive right heart failure. The mechanism responsible for the transformation of red clots into fibrotic material remnants has not yet been elucidated. In patients with pulmonary hypertension, the diagnosis is suspected when a ventilation/perfusion lung scan shows mismatched perfusion defects, and confirmed by right heart catheterisation and vascular imaging. Today, in addition to lifelong anticoagulation, treatment modalities include surgery, angioplasty and medical treatment according to the localisation and characteristics of the lesions.This statement outlines a review of the literature and current practice concerning diagnosis and management of CTEPH. It covers the definitions, diagnosis, epidemiology, follow-up after acute pulmonary embolism, pathophysiology, treatment by pulmonary endarterectomy, balloon pulmonary angioplasty, drugs and their combination, rehabilitation and new lines of research in CTEPH.It represents the first collaboration of the European Respiratory Society, the International CTEPH Association and the European Reference Network-Lung in the pulmonary hypertension domain. The statement summarises current knowledge, but does not make formal recommendations for clinical practice.
650    12
$a balónková angioplastika $7 D000800
650    _2
$a chronická nemoc $7 D002908
650    _2
$a endarterektomie $7 D004691
650    _2
$a lidé $7 D006801
650    12
$a plicní hypertenze $7 D006976
650    _2
$a arteria pulmonalis $7 D011651
650    12
$a plicní embolie $7 D011655
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Torbicki, Adam $u Dept of Pulmonary Circulation, Thrombo-embolic Diseases and Cardiology, Center of Postgraduate Medical Education, ECZ-Otwock, Otwock, Poland $u Section editors
700    1_
$a Gopalan, Deepa $u Dept of Radiology, Imperial College Hospitals NHS Trusts, London, UK $u Section editors
700    1_
$a Sitbon, Olivier $u Université Paris-Saclay; Inserm UMR_S 999, Service de Pneumologie, Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France $u Section editors
700    1_
$a Klok, Frederikus A $u Dept of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands $u Section editors
700    1_
$a Lang, Irene $u Medical University of Vienna, Vienna, Austria $u Section editors
700    1_
$a Jenkins, David $u Royal Papworth Hospital, Cambridge University Hospital, Cambridge, UK $u Section editors
700    1_
$a Kim, Nick H $u Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, La Jolla, CA, USA $u Section editors
700    1_
$a Humbert, Marc $u Université Paris-Saclay; Inserm UMR_S 999, Service de Pneumologie, Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France $u Section editors
700    1_
$a Jais, Xavier $u Université Paris-Saclay; Inserm UMR_S 999, Service de Pneumologie, Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France $u Section editors
700    1_
$a Vonk Noordegraaf, Anton $u Dept of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands $u Section editors
700    1_
$a Pepke-Zaba, Joanna $u Royal Papworth Hospital, Cambridge University Hospital, Cambridge, UK $u Section editors
700    1_
$a Brénot, Philippe $u Marie Lannelongue Hospital, Paris-South University, Le Plessis Robinson, France
700    1_
$a Dorfmuller, Peter $u University of Giessen and Marburg Lung Center, German Center of Lung Research (DZL), Giessen, Germany $u Dept of Medicine, Imperial College London, London, UK $u Dept of Pneumology, Kerckhoff-Clinic Bad Nauheim, Bad Nauheim, Germany
700    1_
$a Fadel, Elie $u Hannover Medical School, Hannover, Germany
700    1_
$a Ghofrani, Hossein-Ardeschir $u University of Giessen and Marburg Lung Center, German Center of Lung Research (DZL), Giessen, Germany $u Dept of Medicine, Imperial College London, London, UK $u Dept of Pneumology, Kerckhoff-Clinic Bad Nauheim, Bad Nauheim, Germany
700    1_
$a Hoeper, Marius M $u Hannover Medical School, Hannover, Germany
700    1_
$a Jansa, Pavel $u 2nd Department of Medicine, Dept of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Madani, Michael $u Sulpizio Cardiovascular Centre, University of California, San Diego, CA, USA
700    1_
$a Matsubara, Hiromi $u National Hospital Organization Okayama Medical Center, Okayama, Japan
700    1_
$a Ogo, Takeshi $u National Cerebral and Cardiovascular Centre, Osaka, Japan
700    1_
$a Grünig, Ekkehard $u Thoraxklinik Heidelberg at Heidelberg University Hospital, Heidelberg, Germany
700    1_
$a D'Armini, Andrea $u Unit of Cardiac Surgery, Intrathoracic Transplantation and Pulmonary Hypertension, University of Pavia School of Medicine, Foundation I.R.C.C.S. Policlinico San Matteo, Pavia, Italy
700    1_
$a Galie, Nazzareno $u University of Bologna, Bologna, Italy
700    1_
$a Meyer, Bernhard $u Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany
700    1_
$a Corkery, Patrick $u PHA Ireland, Dublin, Ireland $u Patient representative
700    1_
$a Meszaros, Gergely $u PHA Europe, Hungary $u Patient representative
700    1_
$a Mayer, Eckhard $u Dept of Thoracic Surgery, Kerckhoff Clinic Bad Nauheim, Bad Nauheim, Germany $u Equal contribution $u Co-chair
700    1_
$a Simonneau, Gérald $u Université Paris-Saclay; Inserm UMR_S 999, Service de Pneumologie, Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France $u Equal contribution $u Co-chair
773    0_
$w MED00001660 $t The European respiratory journal $x 1399-3003 $g Roč. 57, č. 6 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33334946 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133720 $b ABA008
999    __
$a ok $b bmc $g 1714560 $s 1146067
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 57 $c 6 $e 20210617 $i 1399-3003 $m The European respiratory journal $n Eur Respir J $x MED00001660
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options